Number of the records: 1
butionínsulfoximín
SYS d019328 LBL 00000nz--a2200000o--4500 005 20250606214320.9 008 960610|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 065 $a D02.886.030.676.620.125 065 $a D12.125.166.676.620.125 066 $a 01 $c 03 150 $a butionínsulfoximín $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 550 $7 sllk_us_auth*d000963 $Y Antimetabolites $w P $a antimetabolity 550 $7 sllk_us_auth*d000964 $Y Antimetabolites, Antineoplastic $w P $a antimetabolity protinádorové 550 $7 sllk_us_auth*d004791 $Y Enzyme Inhibitors $w P $a inhibítory enzýmov 550 $7 sllk_us_auth*d011837 $Y Radiation-Protective Agents $w P $a látky rádioprotektívne 550 $7 sllk_us_auth*d011838 $Y Radiation-Sensitizing Agents $w P $a rádiosenzibilizátory 665 $a 97: was BUTHIONINE SULFOXIMINE (NM) 1979-96 $2 eng 665 $a Methionine Sulfoximine (1979-1996) $2 eng 680 9-
$i A synthetic amino acid that depletes glutathione by irreversibly inhibiting gamma-glutamylcysteine synthetase. Inhibition of this enzyme is a critical step in glutathione biosynthesis. It has been shown to inhibit the proliferative response in human T-lymphocytes and inhibit macrophage activation. (J Biol Chem 1995;270(33):1945-7) $2 eng 750 -2
$a Buthionine Sulfoximine $2 eng 980 $x M
Number of the records: 1